Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.

The American journal of pathology - 1 Oct 2010

Ho Karen J, Spite Matthew, Owens Christopher D, Lancero Hope, Kroemer Alex H K, Pande Reena, Creager Mark A, Serhan Charles N, Conte Michael S

Abstract excerpt

Atherosclerosis is a chronic inflammatory disease of the vessel wall. Recent evidence suggests that chronic vascular inflammation ensues as an imbalance between pro- and anti-inflammatory mediators. Recently identified lipid mediators (eg, lipoxins and resolvins) play active roles in promoting the resolution of inflammation. Alterations in vascular smooth muscle cell (VSMC) phenotype, which manifest as a loss of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Aspirin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Eicosapentaenoic Acid

Share to Peripheral Arterial Disease

Share to Platelet-Derived Growth Factor

Share to Receptors, Chemokine

Share to Receptors, Platelet-Derived Growth Factor

Share to Saphenous Vein

Source

Open in PubMed Open full text

Identifiers

PMID: 20709806
DOI: 10.2353/ajpath.2010.091082
PMCID: PMC2947304

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.PMID 20709806Read ↗

Differential Regulation of Inflammatory and Pro-Resolving Lipid Mediators in Chronic Coronary Syndrome Across Cardiometabolic Phenotypes.Semantic proximity Read ↗

Maresin 1 induces a novel pro-resolving phenotype in human platelets.Semantic proximity Read ↗

The roles of mechanotransduction, vascular wall cells, and blood cells in atheroma induction.Semantic proximity Read ↗

Myocardin regulates vascular smooth muscle cell inflammatory activation and disease.Semantic proximity Read ↗

Recent insights into the cellular biology of atherosclerosisSemantic proximity Read ↗

Characterization of the inflammatory phenotype in atherosclerosis may contribute to the development of new therapeutic and preventative interventions.Semantic proximity Read ↗

Inflammation: a trigger for acute coronary syndrome.Semantic proximity Read ↗

Role of Diverse Smooth Muscle Cell Phenotypic Transitions in Atherosclerosis Development and Late-Stage Pathogenesis.Semantic proximity Read ↗

Macrophages in Atherosclerosis Regression.Semantic proximity Read ↗

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.Semantic proximity Read ↗

Peroxisome proliferator-activated receptor δ improves the features of atherosclerotic plaque vulnerability by regulating smooth muscle cell phenotypic switching.Semantic proximity Read ↗

Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.